International Clinical Trial: A Clinical Study Evaluating the Efficacy and Safety of 8 mg Aflibercept Using a Flexible Treat-and-Extend (T&E) Regimen in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration (nAMD)

Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134826) titled 'A Clinical Study Evaluating the Efficacy and Safety of 8 mg Aflibercept Using a Flexible Treat-and-Extend (T&E) Regimen in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration (nAMD)' on Oct. 21.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Qilu Hospital of Shandong University

Condition: Age-related Macular Degeneration

Intervention: Aflibercept 3+T&E treatment group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-11-01

Target Sample Size: Aflibercept 3+T&E treatment group:24;Aflibercept 2+T&E treatment group:24; ...